Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis
Background Hepatorenal syndrome is defined as renal failure in people with cirrhosis in the
absence of other causes. In addition to supportive treatment such as albumin to restore fluid …
absence of other causes. In addition to supportive treatment such as albumin to restore fluid …
Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis
H Wang, A Liu, W Bo, X Feng, Y Hu - Medicine, 2018 - journals.lww.com
Background: Hepatorenal syndrome is a fatal complication of advanced cirrhosis.
Terlipressin is the most widely used treatment method, however, the therapy effects remain …
Terlipressin is the most widely used treatment method, however, the therapy effects remain …
Terlipressin and the treatment of hepatorenal syndrome: how the CONFIRM trial moves the story forward
Hepatorenal syndrome (HRS) is a form of acute kidney injury (AKI) occurring in patients with
advanced cirrhosis and is associated with significant morbidity and mortality. The …
advanced cirrhosis and is associated with significant morbidity and mortality. The …
Expert consensus on the use of human serum albumin in critically ill patients
YT Yu, J Liu, B Hu, RL Wang, XH Yang… - Chinese medical …, 2021 - mednexus.org
Human serum albumin (HSA) is a non-glycosylated, negatively charged, single-chain
polypeptide composed of 585 amino acid residues with a relative molecular mass of 66.438 …
polypeptide composed of 585 amino acid residues with a relative molecular mass of 66.438 …
Epidemiology, pathophysiology, and management of hepatorenal syndrome
Acute kidney injury (AKI) is a common presentation in patients with advanced cirrhosis
hospitalized with acute decompensation. A new revised classification now divides AKI in …
hospitalized with acute decompensation. A new revised classification now divides AKI in …
Norepinephrine is more effective than midodrine/octreotide in patients with hepatorenal syndrome-acute kidney injury: a randomized controlled trial
EI El-Desoki Mahmoud, DH Abdelaziz… - Frontiers in …, 2021 - frontiersin.org
Background: Terlipressin is the first-line pharmacological treatment for hepatorenal
syndrome. When terlipressin is unavailable, midodrine/octreotide or norepinephrine, with …
syndrome. When terlipressin is unavailable, midodrine/octreotide or norepinephrine, with …
Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis‐related hospitalisations in the US
Background Hepatorenal syndrome (HRS) contributes to significant morbidity and mortality
in hospitalised patients with cirrhosis. Aims To examine recent trends, magnitude and …
in hospitalised patients with cirrhosis. Aims To examine recent trends, magnitude and …
Management of liver failure in general intensive care unit
C Paugam-Burtz, E Levesque, A Louvet… - … Critical Care & Pain …, 2020 - Elsevier
Abstract Objective To produce French guidelines on Management of Liver failure in general
Intensive Care Unit (ICU). Design A consensus committee of 23 experts from the French …
Intensive Care Unit (ICU). Design A consensus committee of 23 experts from the French …
Limited progress in hepatorenal syndrome (HRS) reversal and survival 2002–2018: a systematic review and meta-analysis
Introduction Type 1 hepatorenal syndrome (HRS) is a fatal complication of cirrhosis.
Treatments trend toward HRS reversal, but few show clear mortality benefit. We sought to …
Treatments trend toward HRS reversal, but few show clear mortality benefit. We sought to …
[HTML][HTML] Management of hepatorenal syndrome: a review
Acute kidney injury (AKI) occurs frequently in patients with cirrhosis, and hepatorenal
syndrome (HRS) is second most common etiology of AKI after volume responsible pre-renal …
syndrome (HRS) is second most common etiology of AKI after volume responsible pre-renal …